Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083

dc.creatorMarzinke, Mark A.
dc.creatorFogel, Jessica M.
dc.creatorWang, Zhe
dc.creatorPiwowar-Manning, Estelle
dc.creatorKofron, Ryan
dc.creatorMoser, Amber
dc.creatorBhandari, Pradip
dc.creatorGollings, Ryann
dc.creatorBushman, Lane R.
dc.creatorWeng, Lei
dc.creatorHalvas, Elias K.
dc.creatorMellors, John
dc.creatorAnderson, Peter L.
dc.creatorPersaud, Deborah
dc.creatorHendrix, Craig W.
dc.creatorMcCauley, Marybeth
dc.creatorRinehart, Alex R.
dc.creatorClair, Marty St.
dc.creatorFord, Susan L.
dc.creatorRooney, James F.
dc.creatorAdeyeye, Adeola
dc.creatorChariyalertsak, Suwat
dc.creatorMayer, Kenneth
dc.creatorArduino, Roberto C.
dc.creatorCohen, Myron S.
dc.creatorGrinsztejn, Beatriz
dc.creatorHanscom, Brett
dc.creatorLandovitz, Raphael J.
dc.creatorEshleman, Susan H.
dc.date.accessioned2023-06-13T21:08:13Z
dc.date.accessioned2023-09-05T14:48:37Z
dc.date.available2023-06-13T21:08:13Z
dc.date.available2023-09-05T14:48:37Z
dc.date.created2023-06-13T21:08:13Z
dc.date.issued2023
dc.identifierMARZINKE, Mark A. et al. Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083. Antimicrobial Agents and Chemotherapy, v. 67, n. 4, p. 1-13, Apr. 2023.
dc.identifier0066-4804
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/59011
dc.identifier10.1128/aac.00053-23
dc.identifier1098-6596
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8662513
dc.languageeng
dc.publisherAmerican Society for Microbiology
dc.rightsopen access
dc.titleExtended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083
dc.typeArticle


Este ítem pertenece a la siguiente institución